Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
Microbial modulation of diabetes: Short-chain fatty acids (SCFAs) are produced by various human gut microbes. SCFAs act as an energy source to the colonic epithelium and are also sensed by host signaling pathways that modulate appetite and inflammation. Deficiency of gut SCFAs is associated with type 2 diabetes. Zhao et al. found that adopting a high-fiber diet promoted the growth of SCFA-producing organisms in diabetic humans. The high-fiber diet induced changes in the entire gut microbe community and correlated with elevated levels of glucagon-like peptide-1, a decline in acetylated hemoglobin levels, and improved blood-glucose regulation. Science , this issue p. 1151
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, gut bacteria respond to a high-fiber diet as guilds rather than taxa, suggesting that guilds may mediate the beneficial effects of dietary fiber on immunotherapy.152”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [152]
In the citing paper
“Indeed, gut bacteria respond to a high-fiber diet as guilds rather than taxa, suggesting that guilds may mediate the beneficial effects of dietary fiber on immunotherapy.152”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [152]
In the citing paper
“A lower abundance of SCFA-producing bacteria has been associated with higher risk of type 2 diabetes.89”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [89]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Prodigal: prokaryotic gene recognition and translation initiation site identification
Hyatt, D., Chen, G.-L., LoCascio, P. F., Land, M. L., Larimer, F. W., & Hauser, L. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-119 · Cited by 12,587
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015) · Genome Research · doi:10.1101/gr.186072.114 · Cited by 12,496
Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,491
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citation
Research works printed but not linked: 3
- Chinese Diabetes Society, China guideline for type 2 diabetes (2013 edition). Chin. J. Diabetes Mellitus 6, 447–498 (2014).
- Y. Yang G. Wang X. Pan China Food Composition (Book 1 Beijing Medical Univ. Press ed. 2 2009).
- H. Wu, R. Wang, Y. Zhao, X. Pang, J. Shen, C. Zhang, ., Exploring carbohydrate utilization capacity of Bifidobacterium pseudocatenulatum isolated from a morbidly obese child after dietary intervention. Genomics Appl. Biol. 34, 1384–1391 (2015).
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
The impact of dietary fiber on gut microbiota in host health and disease
Makki, K., Deehan, E. C., Walter, J., & Bäckhed, F. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.012 · Cited by 2,517
Role of the gut microbiota in nutrition and health
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
SCFA: mechanisms and functional importance in the gut
Martin-Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P., & Lapaque, N. (2021) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006916 · Cited by 1,480
“Supporting this idea, clinical studies reported that prebiotics and dietary fibres increased the relative abundance of these beneficial SCFA-producing bacteria and butyrate fermentation, leading to the improvement of type-2 diabetes and ulcerative colitis((169,170)).”
ResultCausal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Sanna, S., van Zuydam, N. R., Mahajan, A., Kurilshikov, A., Vich Vila, A., Võsa, U., Mujagic, Z., Masclee, A. A. M., Jonkers, D. M. A. E., Oosting, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0350-x · Cited by 1,539
Chait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529
Gut microbial metabolites in obesity, NAFLD and T2DM
Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0156-z · Cited by 1,493
Gut microbiota-derived metabolites as central regulators in metabolic disorders
Agus, A., Clément, K., & Sokol, H. (2021) · Gut · doi:10.1136/gutjnl-2020-323071 · Cited by 1,347
“The amount of SCFA-producing bacteria and SCFAs is reduced in faecal samples of dysmetabolic mice 62 and in humans with obesity and diabetes.”
BackgroundHuman gut microbiota/microbiome in health and diseases: a review
Gomaa, E. Z. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01474-7 · Cited by 1,294
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
dbCAN3: automated carbohydrate-active enzyme and substrate annotation
Zheng, J., Ge, Q., Yan, Y., Zhang, X., Huang, L., & Yin, Y. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad328 · Cited by 1,084
Short chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103
“A study by Zhao et al. (2018) showed that a diet rich in complex fibre mixtures for 12 weeks decreased haemoglobin A1c levels and fasting blood glucose and improved glucose tolerance by approximately 20% in T2DM individuals.”
Gut Microbiota and Immune System Interactions
Yoo, J., Groer, M., Dutra, S., Sarkar, A., & McSkimming, D. (2020) · Microorganisms · doi:10.3390/microorganisms8101587 · Cited by 1,032
The intestinal microbiota fuelling metabolic inflammation
Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0198-4 · Cited by 1,089
Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis
Portincasa, P., Bonfrate, L., Vacca, M., De Angelis, M., Farella, I., Lanza, E., Khalil, M., Wang, D. Q.-H., Sperandio, M., & Di Ciaula, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031105 · Cited by 969
“SCFA supplementation in patients with T2DM increased the abundance of butyrate-producing bacteria and increased GLP-1 and hemoglobin A1c levels [101].”
BackgroundMethodInfluentialMicrobial Regulation of Host Physiology by Short-chain Fatty Acids
van der Hee, B., & Wells, J. M. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.02.001 · Cited by 980
The gut microbiome: Relationships with disease and opportunities for therapy
Durack, J., & Lynch, S. V. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180448 · Cited by 943
“Recently, a diet rich in fiber was shown to significantly improve glucose control and promote a healthier metabolic profile in T2DM patients (Zhao et al., 2018).”
BackgroundInfluentialThe human gut microbiome in early-onset type 1 diabetes from the TEDDY study
Vatanen, T., Franzosa, E. A., Schwager, R., Tripathi, S., Arthur, T. D., Vehik, K., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., et al. (2018) · Nature · doi:10.1038/s41586-018-0620-2 · Cited by 886
Nogal, A., Valdes, A. M., & Menni, C. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1897212 · Cited by 917
Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration
Leeming, E. R., Johnson, A. J., Spector, T. D., & Le Roy, C. I. (2019) · Nutrients · doi:10.3390/nu11122862 · Cited by 817
“However, these may draw a pre-emptory conclusion with limited dietary and faecal time-points investigating one dietary shift [108].”
BackgroundFassarella, M., Blaak, E. E., Penders, J., Nauta, A., Smidt, H., & Zoetendal, E. G. (2021) · Gut · doi:10.1136/gutjnl-2020-321747 · Cited by 772
“Modulation of the human gut microbiome with dietary interventions has been extensively studied, mainly focusing on the supplementation of NDCs. 74 78 79 However, the impact of dietary components on the stability and resilience of the gut ecosystem has been barely addressed.”
BackgroundMethodShort-chain fatty acids in diseases
Zhang, D., Jian, Y.-P., Zhang, Y.-N., Li, Y., Gu, L.-T., Sun, H.-H., Liu, M.-D., Zhou, H.-L., Wang, Y.-S., & Xu, Z.-X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01219-9 · Cited by 718
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
O'Riordan, K. J., Collins, M. K., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G., Schellekens, H., & Cryan, J. F. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111572 · Cited by 713
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 673
“Further, fiber intake promoted the expansion of SCFAs producing bacteria and improved glucose tolerance (partly via GLP-1) in people with T2D (272) (Figure 6).”
BackgroundCommon principles and best practices for engineering microbiomes
Lawson, C. E., Harcombe, W. R., Hatzenpichler, R., Lindemann, S. R., Löffler, F. E., O’Malley, M. A., García Martín, H., Pfleger, B. F., Raskin, L., Venturelli, O. S., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0255-9 · Cited by 633
The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity
González Hernández, M. A., Canfora, E. E., Jocken, J. W. E., & Blaak, E. E. (2019) · Nutrients · doi:10.3390/nu11081943 · Cited by 624
“Nevertheless, a few human studies have shown the capacity to improve markers of whole-body insulin sensitivity [11,187,190].”
BackgroundResultInfluentialThe impact of the gut microbiota on the reproductive and metabolic endocrine system
Qi, X., Yun, C., Pang, Y., & Qiao, J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1894070 · Cited by 554
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Beam, A., Clinger, E., & Hao, L. (2021) · Nutrients · doi:10.3390/nu13082795 · Cited by 576
“High-fiber diets have been linked to an increase in SCFA production within the gut [48,49].”
BackgroundThe Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study
Wu, H., Tremaroli, V., Schmidt, C., Lundqvist, A., Olsson, L. M., Krämer, M., Gummesson, A., Perkins, R., Bergström, G., & Bäckhed, F. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.011 · Cited by 528
De la Cuesta-Zuluaga, J., Mueller, N., Álvarez-Quintero, R., Velásquez-Mejía, E., Sierra, J., Corrales-Agudelo, V., Carmona, J., Abad, J., & Escobar, J. (2018) · Nutrients · doi:10.3390/nu11010051 · Cited by 533
“Total SCFAs Acetate Propionate Butyrate Isobutyrate OTU Richness Adiposity BMI 0.28 * 0.26 * 0.29 * 0.25 * 0.13 * −0.11 * Body fat 0.13 * 0.12 * 0.14 * 0.11 * 0.09 −0.06 Waist circumference 0.26 * 0.23 * 0.28 * 0.24 * 0.14 * −0.19 * Blood chemistry HDL −0.10 * −0.08 −0.13 * −0.11 * −0.06 0.15 * LDL −0.02 −0.02 −0.01 0…”
BackgroundInfluentialInflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
“The phenomenon of IR is essential to our understanding of the overlap between AD and T2DM.”
BackgroundInfluentialGut microbiota derived metabolites in cardiovascular health and disease
Wang, Z., & Zhao, Y. (2018) · Protein & Cell · doi:10.1007/s13238-018-0549-0 · Cited by 471
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Self-citationDietary Fiber Intake and Gut Microbiota in Human Health
Fu, J., Zheng, Y., Gao, Y., & Xu, W. (2022) · Microorganisms · doi:10.3390/microorganisms10122507 · Cited by 394
“SCFAs were believed to be the crucial molecules that alle- viated diabetes via greater postprandial glucagon-like peptide 1 (GLP-1) and fasting pep- tide YY (PYY) [65].”
BackgroundInfluentialResearch progress in the relationship between type 2 diabetes mellitus and intestinal flora
Ma, Q., Li, Y., Li, P., Wang, M., Wang, J., Tang, Z., Wang, T., Luo, L., Wang, C., Wang, T., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109138 · Cited by 430
Self-citationGut mucosal virome alterations in ulcerative colitis
Zuo, T., Lu, X.-J., Zhang, Y., Cheung, C. P., Lam, S., Zhang, F., Tang, W., Ching, J. Y. L., Zhao, R., Chan, P. K. S., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-318131 · Cited by 423
Self-citationKim, C. H. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00987-1 · Cited by 420
“In this regard, the effects of SCFAs in suppressing metabolic syndrome and type II diabetes (T2DM) have been well established [108, 109].”
BackgroundRole of the gut microbiota in type 2 diabetes and related diseases
Yang, G., Wei, J., Liu, P., Zhang, Q., Tian, Y., Hou, G., Meng, L., Xin, Y., & Jiang, X. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154712 · Cited by 418
Self-citationGut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention
Liu, Y., Wang, Y., Ni, Y., Cheung, C. K. Y., Lam, K. S. L., Wang, Y., Xia, Z., Ye, D., Guo, J., Tse, M. A., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.001 · Cited by 405
Effects of dietary fiber on human health
He, Y., Wang, B., Wen, L., Wang, F., Yu, H., Chen, D., Su, X., & Zhang, C. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.07.001 · Cited by 343
Self-citationDerosa, L., Routy, B., Fidelle, M., Iebba, V., Alla, L., Pasolli, E., Segata, N., Desnoyer, A., Pietrantonio, F., Ferrere, G., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.04.044 · Cited by 398
Whole Fruits and Fruit Fiber Emerging Health Effects
Dreher, M. (2018) · Nutrients · doi:10.3390/nu10121833 · Cited by 370
“A 2018 RCT found that when fiber dependent-SCFA producing bacteria were present with greater diversity and abundance in the microbiota, the subjects had lower HbA1c levels, partly via increased glucagon-like peptide-1 production [239].”
BackgroundBeli, E., Yan, Y., Moldovan, L., Vieira, C. P., Gao, R., Duan, Y., Prasad, R., Bhatwadekar, A., White, F. A., Townsend, S. D., et al. (2018) · Diabetes · doi:10.2337/db18-0158 · Cited by 365
“For example, certain bacteria are shown to induce diabetes (20), whereas others alleviate it (21).”
BackgroundSelf-citationButyrate in Energy Metabolism: There Is Still More to Learn
Zhang, L., Liu, C., Jiang, Q., & Yin, Y. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.12.003 · Cited by 364
Modulating the microbiome to improve therapeutic response in cancer
McQuade, J. L., Daniel, C. R., Helmink, B. A., & Wargo, J. A. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30952-5 · Cited by 376
Diet and the human gut microbiome: An international review
Wilson, A. S., Koller, K. R., Ramaboli, M. C., Nesengani, L. T., Ocvirk, S., Chen, C., Flanagan, C. A., Sapp, F. R., Merritt, Z. T., Bhatti, F., et al. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06112-w · Cited by 369
Soluble Dietary Fiber, One of the Most Important Nutrients for the Gut Microbiota
Guan, Z.-W., Yu, E.-Z., & Feng, Q. (2021) · Molecules · doi:10.3390/molecules26226802 · Cited by 336
Advancing functional and translational microbiome research using meta-omics approaches
Zhang, X., Li, L., Butcher, J., Stintzi, A., & Figeys, D. (2019) · Microbiome · doi:10.1186/s40168-019-0767-6 · Cited by 340
“Although the gut microbiome has long been considered as a potential target for disease treatment [13] and an effective microbiome-targeted dietary intervention approach has been demonstrated [9], commercially available targeted therapeutics for precise modulation of Fig.”
BackgroundSmith, B. J., Miller, R. A., Ericsson, A. C., Harrison, D. C., Strong, R., & Schmidt, T. M. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1494-7 · Cited by 349
“Indeed, ACA was found to modulate the composition of the fecal bacterial community in prediabetic humans [17], and both increase the SCFA production potential inferred from metagenomes and lower fecal pH [18].”
BackgroundWu, K., Yuan, Y., Yu, H., Dai, X., Wang, S., Sun, Z., Wang, F., Fei, H., Lin, Q., Jiang, H., et al. (2020) · Blood · doi:10.1182/blood.2019003990 · Cited by 345
Inflammation in Renal Diseases: New and Old Players
Andrade-Oliveira, V., Foresto-Neto, O., Watanabe, I. K. M., Zatz, R., & Câmara, N. O. S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01192 · Cited by 330
Martín-Peláez, S., Fito, M., & Castaner, O. (2020) · Nutrients · doi:10.3390/nu12082236 · Cited by 330
The Gut Microbiome Influences Host Endocrine Functions
Rastelli, M., Cani, P. D., & Knauf, C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00280 · Cited by 307
Patnode, M. L., Beller, Z. W., Han, N. D., Cheng, J., Peters, S. L., Terrapon, N., Henrissat, B., Le Gall, S., Saulnier, L., Hayashi, D. K., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.011 · Cited by 329
Koh, A., & Bäckhed, F. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.005 · Cited by 309
Burrello, C., Garavaglia, F., Cribiù, F. M., Ercoli, G., Lopez, G., Troisi, J., Colucci, A., Guglietta, S., Carloni, S., Guglielmetti, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07359-8 · Cited by 307
Diabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
“High-fi ber diets, possibly through gut microbiota modulation, increase short-chain fatty acid production, 657 while a ketogenic diet reduces metabolic syndrome-induced allodynia and increases epidermal axon density in mice.”
Dietary Fiber, Gut Microbiota, and Metabolic Regulation—Current Status in Human Randomized Trials
Myhrstad, M. C. W., Tunsjø, H., Charnock, C., & Telle-Hansen, V. H. (2020) · Nutrients · doi:10.3390/nu12030859 · Cited by 275
“The method used for the microbiota analysis was fecal shotgun metagenomics, providing both taxonomic and functional information on the complex microbial communities [44].”
BackgroundMethodInfluentialZhang, J., Sun, Z., Jiang, S., Bai, X., Ma, C., Peng, Q., Chen, K., Chang, H., Fang, T., & Zhang, H. (2019) · mSystems · doi:10.1128/msystems.00017-19 · Cited by 282
“The efficacy of probiotics in regulating and rebuilding the host intestinal microbiome is well recognized, and the probiotic interference strategy has been used to prevent and cure various metabolic diseases, including type 2 diabetes (15), inflammatory bowel disease (IBD)/irritable bowel syndrome (IBS) (16), and hype…”
BackgroundGut microbiota influence in type 2 diabetes mellitus (T2DM)
Cunningham, A. L., Stephens, J. W., & Harris, D. A. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00446-0 · Cited by 270
Interplay between food and gut microbiota in health and disease
Danneskiold-Samsøe, N. B., Dias de Freitas Queiroz Barros, H., Santos, R., Bicas, J. L., Cazarin, C. B. B., Madsen, L., Kristiansen, K., Pastore, G. M., Brix, S., & Maróstica Júnior, M. R. (2019) · Food Research International · doi:10.1016/j.foodres.2018.07.043 · Cited by 268
Li, C., Stražar, M., Mohamed, A. M. T., Pacheco, J. A., Walker, R. L., Lebar, T., Zhao, S., Lockart, J., Dame, A., Thurimella, K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.014 · Cited by 246
Gut microbiota and metabolic syndrome
Wang, P.-X., Deng, X.-R., Zhang, C.-H., & Yuan, H.-J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000696 · Cited by 246
“Zhao et al([72]) reported that patients with T2DM were randomly divided into two groups.”
BackgroundSelf-citationZhang, Z., Tang, H., Chen, P., Xie, H., & Tao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0074-5 · Cited by 251
Myristoleic acid produced by enterococci reduces obesity through brown adipose tissue activation
Quan, L.-H., Zhang, C., Dong, M., Jiang, J., Xu, H., Yan, C., Liu, X., Zhou, H., Zhang, H., Chen, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319114 · Cited by 254
Self-citationRodriguez, J., Hiel, S., Neyrinck, A. M., Le Roy, T., Pötgens, S. A., Leyrolle, Q., Pachikian, B. D., Gianfrancesco, M. A., Cani, P. D., Paquot, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319726 · Cited by 250
Wei, W., Wong, C. C., Jia, Z., Liu, W., Liu, C., Ji, F., Pan, Y., Wang, F., Wang, G., Zhao, L., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01418-7 · Cited by 248
Self-citationDietary Fibers from Fruits and Vegetables and Their Health Benefits via Modulation of Gut Microbiota
Cui, J., Lian, Y., Zhao, C., Du, H., Han, Y., Gao, W., Xiao, H., & Zheng, J. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12489 · Cited by 241
Microbiota Metabolites in Health and Disease
McCarville, J. L., Chen, G. Y., Cuevas, V. D., Troha, K., & Ayres, J. S. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-071219-125715 · Cited by 241
Excess body weight: Novel insights into its roles in obesity comorbidities
Zhang, X., Ha, S., Lau, H. C.-H., & Yu, J. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.03.008 · Cited by 228
Liu, X., Huang, D., Lai, C., Qin, L., Zeng, G., Xu, P., Li, B., Yi, H., & Zhang, M. (2019) · Small · doi:10.1002/smll.201900133 · Cited by 248
Self-citationA core microbiome signature as an indicator of health
Wu, G., Xu, T., Zhao, N., Lam, Y. Y., Ding, X., Wei, D., Fan, J., Shi, Y., Li, X., Li, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.019 · Cited by 250
Self-citationStructural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease
Ling, Z., Zhu, M., Yan, X., Cheng, Y., Shao, L., Liu, X., Jiang, R., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.634069 · Cited by 241
Wernimont, S. M., Radosevich, J., Jackson, M. I., Ephraim, E., Badri, D. V., MacLeay, J. M., Jewell, D. E., & Suchodolski, J. S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01266 · Cited by 207
Yao, Y., Yan, L., Chen, H., Wu, N., Wang, W., & Wang, D. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153268 · Cited by 235
Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease
Cong, J., Zhou, P., & Zhang, R. (2022) · Nutrients · doi:10.3390/nu14091977 · Cited by 231
“suggested that T2D could be a consequence of deficiency in SCFAs produced by carbohydrate fermentation in the gut [72].”
BackgroundNew Insights Into Gut-Bacteria-Derived Indole and Its Derivatives in Intestinal and Liver Diseases
Li, X., Zhang, B., Hu, Y., & Zhao, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.769501 · Cited by 224
The Burden of Carbohydrates in Health and Disease
Clemente-Suárez, V. J., Mielgo-Ayuso, J., Martín-Rodríguez, A., Ramos-Campo, D. J., Redondo-Flórez, L., & Tornero-Aguilera, J. F. (2022) · Nutrients · doi:10.3390/nu14183809 · Cited by 194
“However, a major increase in dietary fiber can temporarily reduce diversity, as the microbes that digest fiber become specifically enriched, which leads to a change in composition and reduces diversity through competitive interactions [37].”
BackgroundMunukka, E., Ahtiainen, J. P., Puigbó, P., Jalkanen, S., Pahkala, K., Keskitalo, A., Kujala, U. M., Pietilä, S., Hollmén, M., Elo, L., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02323 · Cited by 237
Dynamic balancing of intestinal short-chain fatty acids: The crucial role of bacterial metabolism
Xu, Y., Zhu, Y., Li, X., & Sun, B. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.02.026 · Cited by 234
Self-citationZuo, K., Li, J., Li, K., Hu, C., Gao, Y., Chen, M., Hu, R., Liu, Y., Chi, H., Wang, H., et al. (2019) · GigaScience · doi:10.1093/gigascience/giz058 · Cited by 235
“Targeted promotionofthegutecosystembyindi-vidualizedinterventionmaypresentanovelecologicalapproach for manipulating the gut microbiota to manage CVD and potentially other dysbiosis-related diseases [61].”
Making Sense of … the Microbiome in Psychiatry
Bastiaanssen, T. F. S., Cowan, C. S. M., Claesson, M. J., Dinan, T. G., & Cryan, J. F. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy067 · Cited by 222
Tan, C., Wu, Q., Wang, H., Gao, X., Xu, R., Cui, Z., Zhu, J., Zeng, X., Zhou, H., He, Y., et al. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1861 · Cited by 222
Bioactive components of mushrooms: Processing effects and health benefits
Yadav, D., & Negi, P. S. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110599 · Cited by 216
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.04.003 · Cited by 212
Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Sircana, A., Framarin, L., Leone, N., Berrutti, M., Castellino, F., Parente, R., De Michieli, F., Paschetta, E., & Musso, G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1057-6 · Cited by 223
Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications
Zhang, L., Chu, J., Hao, W., Zhang, J., Li, H., Yang, C., Yang, J., Chen, X., & Wang, H. (2021) · Mediators of Inflammation · doi:10.1155/2021/5110276 · Cited by 201
“WTP diet is a high dietary fi ber diet based on whole grain, supplemented by traditional Chinese medicine homologous food and probiotics [75].”
The Interaction between Flavonoids and Intestinal Microbes: A Review
Xiong, H.-H., Lin, S.-Y., Chen, L.-L., Ouyang, K.-H., & Wang, W.-J. (2023) · Foods · doi:10.3390/foods12020320 · Cited by 209
Alexander, C., Swanson, K. S., Fahey, G. C., & Garleb, K. A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz004 · Cited by 212
“(38) observed that participants with T2DM who consumed ∼1900 kcal/d of a high-fiber diet (∼37 g fiber/d, 40% soluble fiber) for 12 wk lost more body weight (−4.”
Impact of Gut Microbiota on Host Glycemic Control
Gérard, C., & Vidal, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00029 · Cited by 209
“Nevertheless, a recent randomized clinical study using fecal shotgun metagenomics demonstrated that only a small number of SCFA-producing strains (15 strains from three different phyla) were promoted by dietary fiber supplementation and were able to benefit from this new dietary resource (55).”
BackgroundIntestinal Barrier and Permeability in Health, Obesity and NAFLD
Portincasa, P., Bonfrate, L., Khalil, M., Angelis, M. D., Calabrese, F. M., D’Amato, M., Wang, D. Q.-H., & Di Ciaula, A. (2021) · Biomedicines · doi:10.3390/biomedicines10010083 · Cited by 211
“SCFAs supplementation in patients with type 2 diabetes mellitus increases the abundance of butyrate-producing bacteria, GLP-1, and haemoglobin A1c levels [189].”
BackgroundThe promise of the gut microbiome as part of individualized treatment strategies
Schupack, D. A., Mars, R. A. T., Voelker, D. H., Abeykoon, J. P., & Kashyap, P. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00499-1 · Cited by 217
Zhang, S., Zhao, J., Xie, F., He, H., Johnston, L. J., Dai, X., Wu, C., & Ma, X. (2021) · Obesity Reviews · doi:10.1111/obr.13316 · Cited by 209
Xu, J., Liang, R., Zhang, W., Tian, K., Li, J., Chen, X., Yu, T., & Chen, Q. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.12986 · Cited by 209
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Xiao, Y.-L., Gong, Y., Qi, Y.-J., Shao, Z.-M., & Jiang, Y.-Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01771-x · Cited by 202
“414 In addition, increased fi ber consumption is associated with decreased insulin resistance, the mechanism of which mainly includes the gut microbiota and associated molecules.”
BackgroundMeat and Human Health—Current Knowledge and Research Gaps
Geiker, N. R. W., Bertram, H. C., Mejborn, H., Dragsted, L. O., Kristensen, L., Carrascal, J. R., Bügel, S., & Astrup, A. (2021) · Foods · doi:10.3390/foods10071556 · Cited by 170
“Thus, fortification of processed meat with inulin enhanced the formation of acetate, propionate and butyrate, the characteristic short-chain fatty acids that have been identified as pivotal in the beneficial effects associated with dietary fiber consumption [68,69].”
Background
Metadata
- Authors
- Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., Yu, L., Xu, C., Ren, Z., Xu, Y., Xu, S., Shen, H., Zhu, X., Shi, Y., Shen, Q., Dong, W., Liu, R., Ling, Y., Zeng, Y., Wang, X., Zhang, Q., Wang, J., Wang, L., Wu, Y., Zeng, B., Wei, H., Zhang, M., Peng, Y., & Zhang, C.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Shanghai Jiao Tong University (CN)
- Sijing Community Health Service Center of Songjiang District, Shanghai 201601, China.
- Sijing Hospital of Songjiang District, Shanghai 201601, China.
- Department of Endocrinology and Metabolism, Qidong People’s Hospital, Jiangsu 226200, China.
- Army Medical University (CN)
- Corresponding author
- Zhao, Liping
- Zhang, Feng
- Ding, Xiaoying
- Wu, Guojun
- Lam, Yan Y.
- Peng, Yongde
- Zhang, Chenhong
- ORCID
- Venue
- Science
- Published
- 2018-03-09
- Volume
- 359
- Issue
- 6380
- Pages
- 1151-1156
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2789495752
- Cited by
- 2,304
- References
- 63
- Citations by year
- 2026: 208 · 2025: 286 · 2024: 270 · 2023: 301 · 2022: 347 · 2021: 307 · 2020: 285 · 2019: 216 · 2018: 81
- FWCI
- 79.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31330005, 81401141, 81370904)
- Science and Technology Commission of Shanghai Municipality (14YF1402200)
- Key Projects of Shanghai Municipal Health Bureau Research Fund (201440033)
- Shanghai Jiao Tong University Research Funding on Medical and Engineering Interdisciplinary Projects (YG2015ZD08)
- Songjiang District Health Bureau of Climbing Medical Program (0702N14003)
- Shanghai Shen Kang Hospital Development Center for chronic disease prevention and control project (SHDC12015304)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, dietary fiber, short-chain fatty acids, SCFA-producing bacteria, fecal microbiota transplantation, glucagon-like peptide-1, HbA1c, indole, hydrogen sulfide, carbohydrate fermentation, isocaloric diet
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Bacteria, China, Diabetes Mellitus, Type 2, Diet, Dietary Fiber, Fatty Acids, Volatile, Feces, Female, Fermentation, Glycated Hemoglobin, Humans, Hydrogen Sulfide, Indoles, Male, Middle Aged, Glucagon-Like Peptide 1, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.